|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donepudi MS, Kondapalli K, Amos SJ and
Venkanteshan P: Breast cancer statistics and markers. J Cancer Res
Ther. 10:506–511. 2014.PubMed/NCBI
|
|
3
|
Weigelt B, Eberle C, Cowell CF, Ng CK and
Reis-Filho JS: Metaplastic breast carcinoma: More than a special
type. Nat Rev Cancer. 14:147–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Denkert C, Liedtke C, Tutt A and von
Minckwitz G: Molecular alterations in triple-negative breast
cancer-the road to new treatment strategies. Lancet. 389:2430–2442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bianchini G, Balko JM, Mayer IA, Sanders
ME and Gianni L: Triple-negative breast cancer: Challenges and
opportunities of a heterogeneous disease. Nat Rev Clin Oncol.
13:674–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wojciak-Stothard B and Ridley AJ: Rho
GTPases and the regulation of endothelial permeability. Vascul
Pharmacol. 39:187–199. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kamai T, Yamanishi T, Shirataki H, Takagi
K, Asami H, Ito Y and Yoshida K: Overexpression of RhoA, Rac1, and
Cdc42 GTPases is associated with progression in testicular cancer.
Clin Cancer Res. 10:4799–4805. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rihet S, Vielh P, Camonis J, Goud B,
Chevillard S and de Gunzburg J: Mutation status of genes encoding
RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human
colorectal and breast tumors. J Cancer Res Clin Oncol. 127:733–738.
2001.PubMed/NCBI
|
|
9
|
Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y
and Fan D: Expression of seven main Rho family members in gastric
carcinoma. Biochem Biophys Res Commun. 315:686–691. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simpson KJ, Dugan AS and Mercurio AM:
Functional analysis of the contribution of RhoA and RhoC GTPases to
invasive breast carcinoma. Cancer Res. 64:8694–8701. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cote JF and Vuori K: GEF what? Dock180 and
related proteins help Rac to polarize cells in new ways. Trends
Cell Biol. 17:383–393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T,
Yiin JJ, Lu S, Keezer S, Fenton T, et al: Activation of Rac1 by
Src-dependent phosphorylation of Dock180 (Y1811) mediates
PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin
Invest. 121:4670–4684. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gumienny TL, Brugnera E, Tosello-Trampont
AC, Kinchen JM, Haney LB, Nishiwaki K, Walk SF, Nemergut ME, Macara
IG, Francis R, et al: CED-12/ELMO, a novel member of the
CrkII/Dock180/Rac pathway, is required for phagocytosis and cell
migration. Cell. 107:27–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim K, Lee J, Lee SA, Moon H, Park B, Kim
D, Joo YE and Park D: Intermolecular steric inhibition of Ephexin4
is relieved by Elmo1. Sci Rep. 7:44042017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hamoud N, Tran V, Croteau LP, Kania A and
Cote JF: G-protein coupled receptor BAI3 promotes myoblast fusion
in vertebrates. Proc Natl Acad Sci USA. 111:3745–3750. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hochreiter-Hufford AE, Lee CS, Kinchen JM,
Sokolowski JD, Arandjelovic S, Call JA, Klibanov AL, Yan Z, Mandell
JW and Ravichandran KS: Phosphatidylserine receptor BAI1 and
apoptotic cells as new promoters of myoblast fusion. Nature.
497:263–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katoh H and Negishi M: RhoG activates Rac1
by direct interaction with the Dock180-binding protein Elmo.
Nature. 424:461–464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park D and Ravichandran KS: Emerging roles
of brain-specific angiogenesis inhibitor 1. Adv Exp Med Biol.
706:167–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park D, Tosello-Trampont AC, Elliott MR,
Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW and Ravichandran KS:
BAI1 is an engulfment receptor for apoptotic cells upstream of the
ELMO/Dock180/Rac module. Nature. 450:430–434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao Y, Peng Y, Wan J, Tang G, Chen Y,
Tang J, Ye WC, Ip NY and Shi L: The atypical guanine nucleotide
exchange factor Dock4 regulates neurite differentiation through
modulation of Rac1 GTPase and actin dynamics. J Biol Chem.
288:20034–20045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laurin M, Huber J, Pelletier A, Houalla T,
Park M, Fukui Y, Haibe-Kains B, Muller WJ and Côté JF: Rac-specific
guanine nucleotide exchange factor DOCK1 is a critical regulator of
HER2-mediated breast cancer metastasis. Proc Natl Acad Sci USA.
110:7434–7439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I,
Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R and Cheng
SY: ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange
factor, promote human glioma cell invasion. Cancer Res.
67:7203–7211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grimsley CM, Kinchen JM, Tosello-Trampont
AC, Brugnera E, Haney LB, Lu M, Chen Q, Klingele D, Hengartner MO
and Ravichandran KS: Dock180 and ELMO1 proteins cooperate to
promote evolutionarily conserved Rac-dependent cell migration. J
Biol Chem. 279:6087–6097. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Dai JM, Che YL, Gao YM, Peng HJ,
Liu B, Wang H and Linghu H: Elmo1 helps dock180 to regulate Rac1
activity and cell migration of ovarian cancer. Int J Gynecol
Cancer. 24:844–850. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balassa T, Berta G, Jakab L, Bohonyi N and
Szekeres-Bartho J: The effect of the Progesterone-Induced Blocking
Factor (PIBF) on E-cadherin expression, cell motility and invasion
of primary tumour cell lines. J Reprod Immunol. 125:8–15. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sanders MA, Ampasala D and Basson MD:
DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell
spreading and migration on collagen IV. J Biol Chem. 284:27–35.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi L, Zhang B, Sun X, Zhang X, Lv S, Li
H, Wang X, Zhao C, Zhang H, Xie X, et al: CC chemokine ligand 18
(CCL18) promotes migration and invasion of lung cancer cells by
binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway. Mol
Carcinog. 55:2051–2062. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tajiri H, Uruno T, Shirai T, Takaya D,
Matsunaga S, Setoyama D, Watanabe M, Kukimoto-Niino M, Oisaki K,
Ushijima M, et al: Targeting ras-driven cancer cell survival and
invasion through selective inhibition of DOCK1. Cell Rep.
19:969–980. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu S, Papadopoulou N, Nasir O, Föller M,
Alevizopoulos K, Lang F and Stournaras C: Activation of membrane
androgen receptors in colon cancer inhibits the prosurvival signals
Akt/bad in vitro and in vivo and blocks migration via
vinculin/actin signaling. Mol Med. 17:48–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang C, Rajfur Z, Yousefi N, Chen Z,
Jacobson K and Ginsberg MH: Talin phosphorylation by Cdk5 regulates
Smurf1-mediated talin head ubiquitylation and cell migration. Nat
Cell Biol. 11:624–630. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sieg DJ, Hauck CR, Ilic D, Klingbeil CK,
Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates
growth-factor and integrin signals to promote cell migration. Nat
Cell Biol. 2:249–256. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dreissigacker U, Mueller MS, Unger M,
Siegert P, Genze F, Gierschik P and Giehl K: Oncogenic K-Ras
down-regulates Rac1 and RhoA activity and enhances migration and
invasion of pancreatic carcinoma cells through activation of p38.
Cell Signal. 18:1156–1168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gulhati P, Bowen KA, Liu J, Stevens PD,
Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T and Evers
BM: mTORC1 and mTORC2 regulate EMT, motility, and metastasis of
colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res.
71:3246–3256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Parri M and Chiarugi P: Rac and Rho
GTPases in cancer cell motility control. Cell Commun Signal.
8:232010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao Y, Li J, Xing Y, Wang J, Lu C, Xin X
and Geng M: N-acetylglucosaminyltransferase V mediates cell
migration and invasion of mouse mammary tumor cells 4TO7 via RhoA
and Rac1 signaling pathway. Mol Cell Biochem. 309:199–208. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baugher PJ, Krishnamoorthy L, Price JE and
Dharmawardhane SF: Rac1 and Rac3 isoform activation is involved in
the invasive and metastatic phenotype of human breast cancer cells.
Breast Cancer Res. 7:R965–R974. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bourguignon LY, Zhu H, Shao L and Chen YW:
CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic
acid-mediated breast tumor cell migration. J Biol Chem.
275:1829–1838. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Burbelo P, Wellstein A and Pestell RG:
Altered Rho GTPase signaling pathways in breast cancer cells.
Breast Cancer Res Treat. 84:43–48. 2004. View Article : Google Scholar : PubMed/NCBI
|
